CancerCare® Co-Payment Assistance Foundation recently announced the launch of its new website and customer relationship management software, DiseaseTrak.
Along with the implementation of DiseaseTrak, a customer-service platform, the Foundation will now provide same-day determination and conditional approval. The technology will benefit people coping with cancer by allowing faster access to co-payment assistance.
“This tool will drastically improve patient access to treatment,” said the Foundation’s Director, Michele
McCourt. “The process is easy, fast, and seamless.”
Real-Time Information
Patients will also have real-time insight into their status and eliminate the wait and uncertainty regarding co-payment assistance. Both patients and health-care providers will experience an enhanced level of customer service because the site closely monitors each individual’s unique treatment regimen, dispensing history, and medication usage. The site provides reminder tools and an interactive calendar to assist patients in managing their care. Grants and payments can also be closely tracked.
Affiliated with CancerCare, the CancerCare Co-Payment Assistance Foundation is also able to provide immediate access to the full array of CancerCare’s free support services, including online and telephone counseling, support groups, resource referrals, publications, education, and financial assistance with treatment-related expenses such as transportation and child care.
“We have found that co-payment assistance coupled with a network of professional emotional, and practical support improves quality of care for the patient and their loved ones. Combination of the two is the enhanced value the CancerCare Co-Payment Assistance Foundation brings to the table,” said John Rutigliano, CancerCare Chief Operating Officer.
The new CancerCare® Co-Payment Assistance Foundation website will launch simultaneously to ensure easier navigation between it, CancerCare, and the new application system.
For more information, visit http://cancercarecopay.org/. ■
